In conclusion, a sub-30 nm biocompatible lipid nanoparticle Cur@α-NTP-LNs was constructed, exhibiting SR-B1 targeting ability and synergistically enhanced inhibitory effect on NPC tumor growth and its metastasis. Here, SCARB1 is linked to nasopharyngeal carcinoma.